CompanyPrivatePhiladelphia, PA

Alveus Therapeutics, Inc

SEC EDGAR ClinicalTrials.gov

10-QAug 6Latest SEC filing, period to Jun 30

Form DJan 14$57M sold

September 2026

Alveus registers Phase 2 trial of ALV-100 for weight-loss maintenance after semaglutide

Sep 24Trial updateAlveus Therapeutics, Inc semaglutide